P. Yogeeswari et al. / IL FARMACO 59 (2004) 609–613
613
[10] H. Tanimukai, M. Inui, S. Hariguchi, Z. Kaneko, Antiepileptic prop-
erty of inhibitors of carbonic anhydrase, Biochem. Pharmacol. 14
(1965) 961–970.
[11] M.P. Feely, M. O’Callaghan, D. O’Driscoll, N. Callaghan, Sulthiame
in previously untreated epilepsy, Ir. J. Med. Sci. 151 (1982) 175179.
[12] H.-K. Song, K. Hamada, K. Yagi, M. Seino, Effects of single and
repeated administration of sulthiame on amygdaloid kindled seizures
in rats, Epilepsy Res. 27 (1997) 81–87.
[13] M. Madeja, C. Wolf, E.-J. Speckmann, Reduction of voltage-operated
sodium currents by the anticonvulsant drug sulthiame, Brain Res. 900
(2001) 88–94.
[14] K.S. Oles, J.K. Penry, D.L.W. Cole, G. Howard, Use of acetazolamide
as an adjunct to carbamazepine in refractory partial seizures, Epilep-
sia 30 (1989) 74–78.
[15] G.F. Holland, W.H. Funderburk, K.F. Finger, Preparation and Anti-
convulsantActivity of N-Substituted Benzenedisulfonamides, J. Med.
Chem. 6 (1963) 307–312.
[16] G.H. Hamor, B.L. Reavlin, Anticonvulsants 3. Alkyl esters of
4-bromo-2-sulfamoylbenzoic acid and 4-chloro-2-sulfamoylbenzoic
acid, J. Pharm. Sci. 56 (1967) 134–136.
The p-hydroxy compound 9 was found to have prolonged
activity at 100mg/kg compared to the unsubstituted com-
pound 8. Replacement of phenyl ring with cyclohexanone
ring (15) has also exhibited marked anticonvulsant activity in
both i.p. and oral MES screens.
In conclusion, the present results indicate that the com-
pounds possessed marked anticonvulsant activity as indi-
cated by their prevention of the effects of strychnine or
maximal electroshock induced seizures in resemblance to
other sulphonamido derivatives reported earlier [16,24].
Hence these compounds in addition to their action at the
sodium channels, might also act through glycine receptors.
And the primary amino group of semicarbazone is found to
be not essential for anticonvulsant activity and groups like
4-sulphamoylphenyl is beneficial.
[17] Y. Masuda, T. Karasawa, Y. Shiraishi, M. Hori, K. Yoshida,
M. Shimizu, 3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of
anticonvulsant drug. Pharmacological profile, Arzneim.-Forsch.
/Drug Res. 30 (1980) 477–483.
[18] A.A. Saleh, S.M.E. Khalil, M.F. Eid, M.A. El-Ghamry, Synthesis,
spectral and magnetic studies of mononuclear and binuclear Mn(Ii),
Co(Ii), Ni(Ii) and Cu(Ii) Complexes with semicarbazone ligands
derived from sulfonamide, J. Coord, Chem. 56 (2003) 467–480.
[19] D. Wertheim, Synthesis of 4-bromophenyl urea, J.Am. Chem. Soc. 42
(1920) 2303–2304.
[20] S.N. Pandeya, P. Yogeeswari, E. Sausville, A.B. Mauger, V.L. Naray-
anan, Synthesis and antitumour activity of some aryl semicarbazones,
Sci. Pharm. 68 (2000) 369–377.
[21] R.L. Krall, J.K. Penry, B.G. White, H.J. Kupferberg, E.A. Swinyard,
Antiepileptic drug development: II. Anticonvulsant drug screening,
Epilepsia 19 (1978) 409–428.
[22] R.J. Porter, J.J. Cereghino, G.D. Gladding, B.J. Hessie, H.J. Kupfer-
berg, B. Scoville, B.G. White, Antiepileptic Drug Development Pro-
gram, Cleveland Clin. Quart. 51 (1984) 293–305.
[23] H.J. Kupferberg, Antiepileptic drug development program: a coopera-
tive effort of government and industry, Epilepsia 30 (Suppl.1) (1989)
S51–S56.
[24] G.H. Hamor, N. Farraj, Synthesis and anticonvulsant activity of some
alkyl esters of 6-chloro-2-sulfamoylbenzoic acid, J. Pharm. Sci. 54
(1965) 1225–1268.
References
[1] R. Hess, in: H.H. Frey, D. Janz (Eds.), Antiepileptic Drugs, Springer-
Verlag, Berlin, 1985, pp. 35–54.
[2] M.J. Brodie, Established anticonvulsants and treatment of refractory
epilepsy, Lancet 336 (1990) 350–354.
[3] J.R. Dimmock, K.K. Sidhu, R.S. Thayer, P. Mack, M.J. Dutty,
R.S. Reid, J.W. Quail, Anticonvulsant activities of some arylsemicar-
bazones displaying potent oral activity in the maximal electroshock
screen in rats accompanied by high protection indices, J. Med. Chem.
36 (1993) 2243–2252.
[4] S.N. Pandeya, N. Aggarwal, J.S. Jain, Evaluation of semicarbazones
for anticonvulsant and sedative-hypnotic properties, Pharmazie 54
(1999) 300–302.
[5] S.N. Pandeya, V. Mishra, P.N. Singh, D.C. Rupainwar,Anticonvulsant
activity of thioureido derivatives of acetophenone semicarbazone,
Pharmacol. Res. 37 (1998) 17–22.
[6] S.N. Pandeya, P. Yogeeswari, J.P. Stables, Synthesis and anticonvul-
sant activity of 4-bromophenyl substituted aryl semicarbazones, Eur.
J. Med. Chem. 35 (2000) 879–886.
[7] J.R. Dimmock, K.K. Sidhu, S.D. Tumber, S.K. Basran, M. Chen,
J.W. Quail, J.Yang, I. Rozas, D.F. Weaver, Some aryl semicarbazones
possessing anticonvulsant activities, Eur. J. Med. Chem. 30 (1995)
287–301.
[8] S.N. Pandeya, I. Ponnilavarasan, A. Pandey, R. Lakhan, J.P. Stables,
Evaluation of p-nitrophenyl substituted semicarbazones for anticon-
vulsant properties, Pharmazie 54 (1999) 923–925.
[9] I.E. Leppik, Antiepileptic drugs in development: prospects for the
near future, Epilepsia 35 (Suppl.4) (1994) S29–S40.
[25] J.R. Dimmock, R.N. Puthucode, J.M. Smith, M. Hetherington,
J.W. Quail, U. Pugazhenthi, T. Lechler, J.P. Stables, (Aryloxy)aryl
semicarbazones and related compounds: a novel class of anticonvul-
sant agents possessing high activity in the maximal electroshock
screen, J. Med. Chem. 39 (1996) 3984–3997.